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1. Introduction
A great interest has emerged in the last years on the impact 
of the gut-brain axis in psychiatric disorders, pointing 
to stressed and unhealthy conditions of the microbial 
communities inside the human gut as possible causes for 
psychological diseases and conditions, such as depression, 
anxiety and schizophrenia (Bastiaansen et al., 2020; Kelly 
et al., 2019). It has been observed that the gut microbiota 
communicates with the brain, exerting effects over several 
neurobiological mechanisms and related systems; among 
these the hypothalamic-pituitary-adrenal axis, the immune 
system, the tryptophan metabolism and the production of 
various neuroactive compounds (Kelly et al., 2019).
For those reasons, the gut microbiota has become a 
new target to obtain antidepressant effects; remarkably, 
the diversity of studies performed and the functional 
redundancy of the microbiome make it difficult to 
understand if specific microbial components are more 
related than others to psychiatric symptoms (Cheung et 
al., 2019).
Since microbiota composition can be modified in a variety 
of ways, such as through the use of probiotics, prebiotics 
and dietary changes (Butler et al., 2019; Cheung et al., 
2019), several clinical and translational studies have been 
published over the years, showing that the prolonged 
prebiotic and probiotic consumption can positively affect 
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Abstract
In a previously published double-blind, placebo-controlled study, we showed that probiotics intake exerted a positive 
effect on sleep quality and a general improvement across time in different aspects of the profile of mood state, like 
sadness, anger, and fatigue in 33 healthy individuals. The present work investigates the impact of the probiotic 
product, constituted of Limosilactobacillus fermentum LF16, Lacticaseibacillus rhamnosus LR06, Lactiplantibacillus 
plantarum LP01 (all former members of Lactobacillus genus), and Bifidobacterium longum 04, on the gut microbiota 
composition of the same cohort through a metabarcoding analysis. Both the placebo and probiotic treatments had a 
significant impact on the microbiota composition. Statistical analysis showed that the microbiota of the individuals 
could be clustered into three groups, or bacteriotypes, at the baseline, and, inherently, bacterial compositions were 
linked to different responses to probiotic and placebo intakes. Interestingly, L. rhamnosus and L. fermentum were 
retrieved in the probiotic-treated cohort, while a bifidogenic effect of maltodextrin, used as placebo, was observed. 
The present study shed light on the importance of defining bacteriotypes to assess the impact of interventions on 
the gut microbiota and allowed to reveal microbial components which could be related to positive effects (i.e. sleep 
quality improvement) to be verified in further studies.
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aspects of mood, anxiety, and cognition in both healthy 
individuals as well as in patients diagnosed with clinical 
psychiatric disorders (Butler et al., 2019; Kelly et al., 2019; 
Marotta et al., 2019). However, in some clinical trials, lack 
of evidence of an effect on depression and related symptoms 
have also been reported either in depressed (Romijn et al., 
2017) as well as in healthy individuals (in particular in older 
adults) (summarised in Butler et al., 2019) even though 
probiotic strains used were also previously successfully 
applied.
Probiotic supplements used in clinical trials for the 
treatment of depression, either alone (Akkasheh et al., 
2016; Chahwan et al., 2019; Pinto-Sanchez et al., 2017), in 
combination with prebiotics (i.e. galactooligosaccharides) 
(Kazemi et al., 2019), or as adjunctive therapy with 
antidepressants (i.e. sertraline) (Eskandarzadeh et al., 2019) 
mainly include Lactobacillus (L. acidophilus, L. helveticus, 
L. brevis, L. casei, and L. salivarius), Lactococcus (L. lactis) 
and Bifidobacterium species (B. bifidum, B. lactis, and B. 
longum). Generally speaking, such treatments led to (1) 
a significant reduction of depression scores on Hospital 
Anxiety and Depression Scale and improvement of the 
cognitive reactivity scores in mild/moderate depression 
patients (Chahwan et al., 2019; Pinto-Sanchez et al., 2017), 
(2) a decrease of the anxiety symptoms in individuals with 
anxiety disorders (Eskandarzadeh et al., 2019) and (3) an 
improvement of the depression scores on Beck Depression 
Inventory in patients with a diagnosis of major depressive 
disorder (MDD) (Akkasheh et al., 2016; Kazemi et al., 2019).
In healthy subjects, administration of probiotics (L. casei 
Shirota, B. bifidum W23, B. lactis W52, L. acidophilus 
W37, L. brevis W63, L. casei W56, L. salivarius W24, and 
L. lactis W19 and W58) improved the mood of subjects 
having lowest baseline mood levels and in general reduced 
the cognitive reactivity to sadness (Benton et al., 2007; 
Steenbergen et al., 2015).
Moreover, in other two studies led by Messaoudi et al. 
(2011) and Mohammadi et al. (2016), a significant reduction 
in overall anxiety and depression scores was shown after 
the treatment with L. helveticus R0052 and B. longum 
R0175 as well as with a polybiotic combination of various 
Lactobacillus strains (L. acidophilus, L. delbrueckii subsp. 
bulgaricus, L. casei, and L. rhamnosus), Bifidobacterium (B. 
breve, B. longum) and Streptococcus thermophilus strains. 
Besides mood, anxiety and depression scores, it has also 
been shown that the short-term administration of L. gasseri 
improved stress-associated symptoms in terms of sleep 
disturbance (Nishida et al., 2019).
Within the framework of the impact of probiotics on 
mood, we have previously reported (Marotta et al., 
2019) on a double-blind, placebo-controlled study on 33 
healthy volunteers who received daily either a probiotic 
mixture containing Limosilactobacillus fermentum LF16, 
Lacticaseibacillus rhamnosus LR06, Lactiplantibacillus 
plantarum LP01 (former members of Lactobacillus genus, 
Zheng et al., 2020), and B. longum 04 in maltodextrin, or 
a maltodextrin-only placebo, for 6 weeks, followed by a 
3-weeks washout (Figure 1). Data obtained showed that the 
probiotics exerted a general improvement and persistence 
over time in different aspects of the mood state, including 
sadness, anger, and fatigue, accompanied by improvement 
in the sleep quality, which indicates that probiotics may 
increase the production of neuroactive precursors involved 
in emotional modulation, brain functions and circadian 
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Figure 1. Experimental design of the study.
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rhythms. These findings corroborated the positive effect 
of probiotics on mental well-being, possibly determining 
changes in cognitive strategies to deal with problems by 
reducing sensitivity to negative situations.
The aim of the present study was to apply metabarcoding 
analysis of the faecal microbiota to determine (1) the 
microbial arrangement at baseline in the same cohort of 
healthy adults, which were randomised based on other 
characteristics, and (2) determine the effects of the 
probiotic and placebo consumption during and after the 
administration.
2. Materials and methods
Sample collection
The samples analysed derives from 33 healthy subjects 
enrolled in the study. Stool samples and psychological 
variables were collected at four time points (see 
Supplementary Table S1): before the intake of probiotic/
placebo (T0), at 3 (T1) and 6 (T2) weeks after the first 
intake and at the end of the third week of washout (T3).
The experimental group received 42 sachets of the 
product (one for each day), each containing 4×109 cfu/
active fluorescent units (AFU) of four probiotic species: 
L. fermentum LF16 (DSM 26956), L. rhamnosus LR06 
(DSM 21981), L. plantarum LP01 (LMG P-21021), and B. 
longum 04 (DSM 23233) in 2.5 g of freeze-dried powder 
mixture containing maltodextrin (around 85% of the total 
weight) (Probiotical S.p.A., Novara, Italy). The control 
group received 42 sachets of placebo, each containing 2.5 g 
of maltodextrin in powder form. The placebo powder was 
indistinguishable from the probiotics powder in colour, 
taste, and smell. Participants were instructed to dissolve the 
powder in water or milk and drink it in the morning with 
breakfast. The probiotic sachets were analysed by Biolab 
Research S.r.l. (Novara, Italy), via flow cytometry (ISO 
19344:2015 IDF 232:2015, ≥4×109 AFU) and plate count 
method (Biolab Research Method 014-06, ≥4×109 cfu) to 
confirm target cell count. Product stability was monitored 
to ensure minimum cell counts were maintained. The study 
was approved by the Ethical committee of Verona Hospital 
(Azienda Ospedaliera Universitaria Integrata, AOUI 
Verona, 766CESC) and it is registered in ClinicalTrials.
gov with the number ID: NCT03539263.
Library preparation and sequencing
The 132 collected samples from 33 healthy subjects 
were stored at -20 °C until analysis. DNA extraction and 
sequencing were performed at BMR Genomics S.r.l. (Padua, 
Italy). DNA was isolated with the Mobio Powerfecal kit (Mo 
Bio Laboratories, Inc., Carlsbad, CA, USA) adapted for 
QIAcube HT extractor (Qiagen, Hilden, Germany). V3-V4 
regions of 16S rRNA gene were amplified with previously 
described primers (Takahashi et al., 2014), modified with 
forward and reverse overhangs necessary for dual index 
library preparation (Illumina protocol (https://web.uri.
edu/gsc/files/16s-metagenomic-library-prep-guide-
15044223-b.pdf ) generating amplicons of ~460 bp. The 
paired-end sequencing of the 16S rRNA gene amplicons 
was performed using the MiSeq Illumina platform (dual-
indexing approach, 2×300 bp) (Illumina, San Diego, CA, 
USA). A mock community was included as control. The 
resulting output was a set of 264 raw files in FASTQ format. 
All the reads have been submitted to SRA archive and are 
available under the bioproject PRJNA644097.
Bioinformatics data analysis
The whole analysis was performed on R (v3.6.1, R Core 
Team, 2019). Primarily, the FASTQ sequences were 
analysed using DADA2 (v1.13) (Callahan et al., 2016), a 
tool that implements an error correction model and allows 
to identify exact sample sequences that differ as little as 
a single nucleotide. The final output of DADA2 was an 
amplicon sequence variant (ASV) table which recorded the 
number of times each ASV was observed in each sample. 
DADA2 was run as described in https://benjjneb.github.
io/dada2/bigdata.html using default parameters. In order 
to improve the overall quality of the sequences, the reads 
were filtered and trimmed using filterAndTrim function 
implemented in DADA2. Consequently, to remove low 
quality bases at the end of reads, the truncLen option was 
set to (280, 220) for the forward and reverse FASTQ files 
respectively. Similarly, to remove adapter sequences at the 
5’ end, the trimLeft option was set to (17, 21), for forward 
and reverse reads respectively. The removeBimeraDenovo 
function was used to remove chimeras, via consensus 
method, and then collapseNoMismatch function collapsed 
together all the reads that are identical up to shifts or length 
variation. Finally, the taxonomic assignment was performed 
using the naïve Bayesian classifier method implemented 
in DADA2 (assignTaxonomy and addSpecies functions) 
using as reference the EzBioCloud 16S database for QIIME 
pipeline (version 2018.05, https://www.ezbiocloud.net/
resources/16s_download), correctly formatted to work 
with the taxonomic classifier implemented within 
DADA2 (https://benjjneb.github.io/dada2/assign.html). 
A phylogenetic tree of the ASVs was obtained using the 
function AlignSeq implemented in DECIPHER (v2.12) 
(Wright, 2016), an R package to create multiple sequence 
alignments. FastTree (v2.1.10) (Price et al., 2010) was used 
to create the final tree.
Data quality assessment and filtering
Rarefaction curves on raw data were evaluated to assess 
the species richness among samples as a function of the 
sequencing depth. Data were pre-processed filtering taxa 
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(ASVs) with low prevalence (where prevalence is the 
fraction of total samples in which an ASV is observed), 
setting a threshold of 0.5% for the cumulative relative 
abundance across all the samples; furthermore, taxa present 
in less than 2 samples were discarded. Synergistetes phylum 
members taxa (cumulative relative abundance = 0.34%) 
and Lentisphaerae phylum members taxa (cumulative 
relative abundance = 0.03%) were discarded by this filter. 
The pre-processing output data were then transformed to 
their relative abundances, and the 10 most present genera 
were plotted to phylum level. Mann-Whitney tests were 
performed on ASVs detected in these genera and the 
Benjamini & Hochberg correction was applied to adjust 
the p-values because of multiple testing.
In order to investigate the presence of probiotic related 
taxa, a further taxonomy classification was performed. 
The softwares Kraken2 (Wood et al., 2019) and Bracken 
(Lu et al., 2017) were used to check both raw .fastq data 
and DADA2 inferred list of ASV, using two different 
pre-built Kraken2/Bracken databases (minikraken2_
v2_8GB_201904, k2_standard_16gb_20200919) and a 
custom database containing bacteria, archaea, virus, fungi 
and plants sequences, built using RefSeq (O’Leary et al., 
2016) sequences.
Biodiversity measurements
Shannon-Wiener index was used to calculate α-diversity, 
which was plotted stratifying the samples according to 
time points, gender and treatment type; the Kruskal-Wallis 
tests were performed to verify statistical differences in the 
α-diversity among the samples. To measure β-diversity, data 
were normalised by three different methods (Cumulative 
Sum Scaling (CSS), Total Sum Scaling (TSS), Rarefaction) 
through the phyloseq_transform_css, phyloseq_standardize_
otu_abundance and rarefy_even_depth functions 
respectively. The first two functions are part of the vmikk/
metagMisc package (github.com/vmikk/metagMisc) 
while the latter belongs to the phyloseq package (v1.30.0) 
(McMurdie and Holmes, 2013). Each type of normalised 
data was inspected using four different distance metrics 
(Unweighted UniFrac, Weighted UniFrac, Bray-Curtis, 
Jaccard) and ordinated using the Principal Coordinates 
Analysis (PCoA) and Detrended Correspondence Analysis 
(DCA) ordination methods, through the ordinate function 
of the Vegan package (v2.5-5) (Oksanen et al., 2019).
A rigorous procedure was applied to evaluate the best 
combination of normalisation, distance metric, and 
ordination method. Normalization based on rarefaction 
was not considered as it performs very similarly to TSS 
due to the similar library sizes between samples.
At first, a hierarchical clustering was applied to the 
β-diversity bidimensional plot at the baseline grouping 
the samples in 3 and 4 groups. To test which of the two 
clustering methods performed better, the homogeneity of 
the cluster dispersions were tested using ANOVA F-test on 
betadisper function’s output. A significant P-value indicated 
that the cluster dispersions were not homogeneous and 
that data needed to be taken with care. Secondly, the 
silhouette value was calculated, that is a measure of how 
similar an object is to its own cluster (cohesion) compared 
to other clusters (separation). The silhouette ranged from 
-1 to +1, where a high value indicated that the object was 
well matched to its own cluster and poorly matched to 
neighbouring clusters. If most objects had a high value, 
then the clustering configuration was appropriate. On the 
other hand, if many samples had a low or negative value, 
then the clustering configuration might have too many or 
too few clusters. Finally, the cluster memberships found 
at the baseline were extended to all the other time points; 
cluster dispersions and silhouette indexes were computed 
again to verify the performances of the clustering on the 
whole dataset.
Mixed effects regression models statistical analysis
Amongst all the tested combinations, the TSS-normalised 
data, ordinated using the PCoA method and the 
unweighted-UniFrac distance metric, showed the most 
consistent results in cluster dispersions homogeneity and 
silhouettes, hence it was chosen for deeper exploration. To 
investigate the biological meaning of each PCoA coordinate, 
mixed-effects regression model analysis was performed on 
each, using the lme function of the nlme package (v3.1-140) 
(Pinheiro et al., 2020).
Firstly, the model formulation involved the Sample variable 
as a random component for each individual, and several 
categorical variables as fixed effects, such as TimePoint, 
Gender, Treatment and their interactions. Since all the 
variables were categorical, the regression framework set a 
baseline formed by TimePoint = T0, Treatment = Placebo 
and Gender = Female samples. Variable significance was 
guaranteed through an iterative process. Starting from the 
complete model, nonsignificant variables were dropped one 
by one. Every time a variable was dropped a log-likelihood 
ratio test (LRT) was performed in order to compare the 
likelihood of the model with the likelihood of the nested 
one (P-value <0.1). This procedure allowed us to reach 
the most informative as well as parsimonious formulation 
of the model. Moreover, two versions of each model were 
compared: the first, where no correlation structure was 
specified, and the second, where the type of correlation was 
specified as an AR(1) process through the option correlation 
= corAR1(form = ~1|Sample) of lme function.
Secondly, mixed-effects regression models were used 
to study correlation between sample variables and the 
PCoA components, with the new information about cluster 
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memberships. The TimePoint, Gender, Treatment and 
Cluster variables were tested in the model, together with 
the interactions between TimePoint and Gender, TimePoint 
and Treatment, TimePoint and Cluster, Treatment and 
Cluster, and TimePoint, Treatment and Cluster. The already 
described model selection procedure was performed to 
choose the best model.
Biomarkers investigation
To retrieve information about the most discriminant 
features (Amplicon Sequence Variants, ASVs) of the clusters 
identified with the hierarchical clustering procedure, a 
discriminant analysis was computed using PLS-DA and 
sPLS-DA methods. Following the default mixOmics (v6.8) 
(Lê Cao et al., 2016; Rohart et al., 2017) pipeline (http://
mixomics.org/case-studies/splsda-srbct/), a pseudo-
count value of 1 was added to the counts table, which was 
then normalized with TSS and centered log-ratio (CLR) 
transformed. At first, the pipeline was performed on the 
clusters at baseline T0 to identify the most discriminant 
ASVs of each group. The discriminant analysis was then 
applied to each significant interaction resulted from the 
mixed-effects models, to investigate the effect of treatments. 
For each interaction a summary image was plotted using 
the HotLoadings function of the homonym package (github.
com/mcalgaro93/HotLoadings), displaying the discriminant 
ASVs loadings and the related heatmap.
Psychological variables analysis
To find significant associations between psychological 
variables, treatments and clusters, Wilcoxon Rank Sum 
tests were performed between time points T0 and T1, T0 
and T2, and T0 and T3 for placebo and probiotics groups. 
The P-values were also corrected for multiple testing using 
the Benjamini-Hochberg correction method.
3. Results
16S metabarcoding sequencing depth and taxonomy 
classification
A total of 5,382,700 paired-end sequences (an average of 
40,778 reads per sample) with a read length of 300 bp were 
obtained from the samples of the 33 subjects summarised 
in Figure 1. After read quality assessment, denoising and 
chimera filtering, 1,728 different ASVs were obtained. ASVs 
artefacts were removed with several filters and a total of 
730 unique ASVs were obtained (Supplementary Figure S1). 
The taxonomy classification allowed to identify 10 phyla, 20 
classes (730 ASVs), 27 orders (728 ASVs), 46 families (727 
ASVs), 170 genera (720 ASVs) and 263 species (273 ASVs). 
The comparison of rarefaction curves (Supplementary 
Figure S2) as a function of sampling depth showed that 
all curves are close to saturation, therefore the richness 
of the samples has been fully observed or sequenced. The 
only exception was for subject number 8 at time point T2 
that had a library size of 538, while the second lower had 
a value of 8,848; for this reason, the former was discarded 
from the analysis.
The most abundant phylum was Firmicutes, with a 
relative frequency of 62.3% followed by Bacteroidetes 
17.9%, Proteobacteria 9.1%, Verrucomicrobia 4.9%, and 
Actinobacteria 4.7%. The remaining ~1% accounted for 
Euryarchaeota, Tenericutes, Saccharibacteria, Fusobacteria 
and Cyanobacteria. At genus level, the most abundant 
populations were Agathobacter, Blautia, Dialister, 
Faecalibacterium, Ruminococcus, Subdoligranulum 
(Firmicutes), Bacteroides (Bacteroidetes), Escherichia 
(Proteobacteria), Akkermansia (Verrucomicrobia), and 
Bifidobacterium (Actinobacteria) (Supplementary Figure 
S3).
α-diversity analysis confirmed that the subjects of the 
cohort were comparable
Samples were stratified according to TimePoint, Treatment 
(placebo or probiotics) and Gender using Shannon-Wiener 
index, as shown in Supplementary Figure S4. No significant 
differences among samples were observed, neither in the 
experimental nor in the control group (Kruskal-Wallis tests 
had P>0.05). This finding was in line with expectations, as 
the subjects enrolled in the study were comparable when 
related to their internal diversity; neither alterations nor 
major shifts were expected on gut microbiota species 
richness or evenness regarding probiotic consumers.
β-diversity analysis revealed three clusters and a strong 
sample-specific effect
The flow chart in Supplementary Figure S5 summarizes the 
following steps of the analysis. All the β-diversity plots are 
shown in Supplementary Figure S6, while the homogeneity 
of cluster dispersions and silhouettes are presented in the 
Supplementary Results S1. The choice of the number of 
clusters was performed using only the samples at T0, which 
represents a snapshot of the microbiome composition 
before any type of treatment and allows to stratify the 
samples according to different bacteriotypes.
The identification of the best combination of number of 
clusters, normalisations, distances, and type of ordinations 
was then chosen. Specifically, the metrics that performed 
better in terms of homogeneity of cluster dispersions 
and silhouette values, when the cluster membership 
was extended also to all the other timepoints, were 
selected. Three clusters grouping with PCoA ordination 
method, based on unweighted UniFrac distances and 
TSS normalisation (Figure 2A-C), produced the most 
consistent results (see Materials and methods ‘Biodiversity 
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TSS normalised data, unifrac distance metric, PCoA ordination method
β−diversity − by cluster
1 2 3Cluster
Figure 2. (A) Bidimensional representation of β-diversity for the samples in TimePoint = T0 (PCoA ordination method on UniFrac 
distance matrix of TSS normalized count data). Coloured by cluster membership obtained cutting the dendrogram in (B) in order 
to obtain 3 groups of individuals (see Methods for details of normalization, distance, and ordination’s choice). (B) Hierarchical 
clustering dendrogram built with the complete linkage method on the euclidean distance matrix. Distance matrix based on 
PCoA1 and PCoA2 coordinates of the β-diversity for the samples in TimePoint = T0 (PCoA ordination method on UniFrac distance 
matrix of TSS normalised count data). (C) Tridimensional representation of β-diversity coloured by cluster membership for the 
samples in all time points (PCoA ordination method on UniFrac distance matrix of TSS normalised count data). (D) Linear mixed 
effects regression model coefficients. Blue (orange) coloured tiles represent a negative (positive) effect of the variable referred 
to the model baseline (TimePoint = T0, Gender = F, Treatment = Placebo, Cluster = 1). Statistically significant (P<0.1) effects are 
represented by red squared tiles.
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measurements’ and Supplementary Results S1 for details). 
Indeed, using these combinations of metrics, the stability of 
the clusters was maximised over time. In other words, the 
clusters identified at T0 tended to be the most consistent 
when the information of cluster membership is extended 
also to the other time points. The underlying idea was that 
the microbial signatures of the bacteriotype we identified at 
T0 should be stable over time, even though individual hosts 
may switch between enterotypes over long time periods 
(Moeller et al., 2012).
The composition of each cluster is reported in Table 1. 
As expected, samples of the same subject tended to form 
close subclusters, regardless the considered time point or 
treatment (Supplementary Figure S7). This suggests that 
the differences among subjects are stronger than the effects 
determined by the treatment.
Mixed-effects regression models found associations 
between β-diversity and sample variables
To inspect the variability held by the first four coordinates 
of the PCoA, four mixed-effect regression models were at 
first estimated without considering cluster membership 
(see Materials and methods). This regression framework 
allowed us to find significant correlations between PCoA 
coordinates and metadata such as Gender, Treatment and 
TimePoint and to remove sample-specific effects. In this 
context, we implicitly considered the Treatment=Placebo, 
Gender=Female, and TimePoint=T0 as the baseline level. As 
shown in Supplementary Figure S8, a correlation between 
the Treatment variable and the fourth component of the 
PCoA was found, while the third component showed a 
statistically significant difference in Gender at time point 
T3 compared to the baseline. This first analysis did not 
allow us to identify any statistically significant effects for 
the interactions between time points and treatments.
To further investigate if adding bacteryotype information 
would help in identifying significant effects for the 
interactions between time points and treatments, new 
mixed effects regression models were estimated adding 
the cluster membership variable as a fixed effect to the 
framework. Several significant interactions between time 
points and treatments were found for the third coordinate 
(Figure 2D): (1) TimePoint = T1, Treatment = Probiotic and 
Cluster = 3; (2) TimePoint = T2, Treatment = Probiotic and 
Cluster = 2; (3) TimePoint = T2, Treatment = Probiotic and 
Cluster = 3; (4) TimePoint = T3, Treatment = Probiotic and 
Cluster = 2. Clusters 2 and 3 were commonly affected by the 
variable TimePoint = T2 compared to the baseline: Cluster 
2 responded later in the treatment (time points T2 and T3) 
while Cluster 3 responded at the beginning (time points T1 
and T2). Although each interaction should be interpreted 
very carefully, these results highlighted a difference between 
the considered variable categories and the baseline (T0, 
Placebo, Cluster 1). Biologically speaking, the identified 
interactions could be an indicator of a distinct effect of 
the treatment considering different groups/bacteriotypes.
sPLS-DA analysis showed that clusters were 
characterised by a specific bacteriotype
A sPLS-DA analysis was performed to identify the most 
discriminant ASVs at the baseline T0. This multivariate 
approach identified two main components which were 
able to discriminate the clusters. The first component 
highlighted 5 taxa associated with Cluster 3 (Figure 3A,B): 
all the members of this group were characterised by the 
presence of SV33, assigned to Methanobrevibacter smithii, 
while 66% of them also displayed Sporobacter, Eubacterium 
and Oscillibacter spp. (SV168, SV256, SV37).
The second component highlighted the top 30 taxa 
associated with Clusters 1, 2 and 3 which created two 
different patterns as shown in the heatmap (Figure 3C,D). 
Cluster 1 individuals showed the general presence of 
Faecalibacterium spp. (SV3, SV14), while Cluster 3 were 
also characterised by Faecalibacterium spp. and Alistipes 
putredinis (SV4 and SV39); in Cluster 2, the second 
component revealed the presence of SV94-Eubacterium 
and SV77-Lachnospiraceae in almost all the members; 50% 
of them were also characterised by Blautia spp. (SV562).
Lacticaseibacillus rhamnosus is the only probiotic SV 
that increases significantly in the probiotic cohort in 
Cluster 1 and 2
The sPLS-DA analysis revealed that SV232, associated with 
L. rhamnosus, was present in the probiotic cohort at time 
point T1 and T2 in Cluster 1 and Cluster 2, respectively 
(Supplementary Results S2 a, g). As for bifidobacteria, SV34 
associated with B. longum was found to increase in Cluster 1 
at T2 (where it was abundant also in the placebo individuals) 
and T3 Supplementary Results S2 e, k). Interestingly, 
other SVs associated with Bifidobacterium spp. displayed 
a different behaviour: SV228 was found to increase in the 
placebo cohort in Cluster 1 at T1 (Supplementary Results 
S2 b), while the relative abundance of SV121 and SV15 
decreased in Cluster 1 and 2 at T3 (Supplementary Results 
S2 l, m). These observations showed that L. rhamnosus is 
Table 1. Cluster membership for individuals at the baseline 
(TimePoint = T0).
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the only probiotic SV that increases during the probiotic 
administration until T1 and T2 in Cluster 1 and Cluster 
2, respectively.
Bacteriotypes changed distinctly in the probiotic and 
placebo cohorts
The probiotic intake in Cluster 1 was associated with an 
increase of Coproiciproducens leptum (Clostridium letpum), 
Romboutsia timonensis and Mogibacterium spp. (SV264, 
SV25 and SV664) from T1 to T3, respectively; the same 
cohort displayed a decrease of SVs related to Butyricimonas 
(SV785), Lachnospira (SV144) and Faecalibacterium spp. 
(SV4) at the same time points (Supplementary Results 
S2 a, e, k). The placebo individuals featured a decrease 
of Butyricimonas, Alistipes, and Ruthenibacterium 
lactatiformans (SV774, SV465 and SV90) and a higher 
abundance of Anaerotignum (SV370), S. thermophilus 
(ST32) and Turicibacter spp. (SV56) from T1 to T3 
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Figure 3. (A) sPLS-DA analysis at the baseline (TimePoint = T0). Loading values represent the 5 discriminant taxa of the first 
component, associated with Cluster 3. Bigger the loading absolute value, stronger the association. (B) Heatmap shows the CLR 
values of the discriminant taxa in all the samples. (C) sPLS-DA analysis at the baseline (TimePoint = T0). Loading values represent 
the first 30 (out of 135) most discriminant taxa of the second component, associated with Cluster 2 and Cluster 1. Bigger the 
loading absolute value, stronger the association. (D) Heatmap shows the CLR values of the discriminant taxa in all the samples.
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Individuals who took probiotics in Cluster 2 showed a 
significant decrease of Ruminococcaceae (SV348) in T2 
(Supplementary Results S2 g) while the placebo group were 
characterised by an increment of Alistipes onderdonkii 
(SV73) and Lachnospiraceae spp. (SV144) in T2 and 
T3, respectively, and a drop of Blautia spp. (SV562) 
and Clostridium spp. (SV512) in the same time points 
(Supplementary Results S2 h, n).
In Cluster 3, Phascolarctobacterium faecium (SV97) and 
Subdoligranulum spp. (SV16) distinguished the probiotic 
cohort at T1 and T2 which, conversely, showed negative 
CLR values for Dialister invisus (SV5) and Eubacterium 
spp. (SV256) at the same time points (Supplementary 
Results S2 d, j); this latter species (SV94) increased together 
with Roseburia hominis (SV161) in the placebo subjects, 
which also showed a decrease of Intestinibacter bartlettii 
(SV63) and Bacteroides (SV47) at T1 and T2, respectively 
(Supplementary Results S2 c, i).
Maltodextrin exerted an effect on the bacteriotype of each 
cluster
Since maltodextrins are included both in the placebo and 
in the probiotic products, their impact on each cluster’s 
bacteriotype (included Cluster 1) was investigated 
(Supplementary Results S3). Focusing on SVs related 
to probiotics, SV34-B. longum generally increased in 
members of Cluster 1 at T2 and T3 and in Cluster 2 at 
T1 (Supplementary Results S3 b, d, g); as for SVs related 
to other Bifidobacterium spp., a general reduction of 
SV121 and SV15 was observed in both probiotic and 
placebo groups in Cluster 1 at T2 and in Cluster 2 at T3 
(Supplementary Results S3 g, h).
Considering other taxa, Cluster 1 was characterised by a 
general increase in relative abundance of S. thermophilus 
(SV32), R. timonensis (SV25), Turicibacter spp. (SV56), and 
a decrease of Butyricimonas spp. (SV774) and Lachnospira 
spp. (SV144) from T1 to T3 (Supplementary Results S3 
a, d, g).
Cluster 2 individuals were characterised by higher levels 
of Faecalibacterium (SV14), and Roseburia inulinivorans 
(SV54) at T1 and T3; while SVs related to Escherichia (SV1), 
Agathobaculum (SV87), Blautia (SV17), and Eubacterium 
(SV94) decreased from T1 to T3 (Supplementary Results 
S3 b, e, h).
Finally, in Cluster 3 positive CRL values were associated 
to Anaerotignum, Pseudoflavonifractor and Sporobacter 
(SV282, SV428, SV145) while negative values were related 
to D. invisus (SV5), Bacteroides (SV140) and Blautia obeum 
(SV29) (Supplementary Results S3 c, f, i).
Sequence variants related to Limosilactobacillus 
fermentum were detected in only one individual treated 
with probiotics
ASVs associated with L. fermentum and L. plantarum, 
included in the probiotic product, were investigated and 
checked through the 16S-based ID tool of EzBioCloud.
net, https://www.ezbiocloud.net/identify; database version 
2020.10.12). SV1273 associated with L. fermentum was 
detected only in one probiotic cohort sample at T1, while 
conflicting results were obtained using different databases 
related to L. plantarum, confirming that the V3-V4 region 
for this species is not informative (Figure 4).
Placebo Probiotic
















L. rhamnosus B. longum
Zoom from 0 to 0.03 of relative abundance
Probiotic species in treatments
Figure 4. The species related to the probiotic compound were 
isolated and plotted in this barplot. The relative abundances 
percentages were zoomed to visualize the portion from 0 
to 0.3 and stratified by time points and treatment type. The 
Bifidobacterium longum species is present in each time point 
for both the treatment types, showing a shared increasing 
trend. Limosilactobacillus fermentum was detected only for the 
second time point (T1) in the probiotic cohort. Lacticaseibacillus 
rhamnosus taxa were detected for both the second and the 
third time points, relative to the probiotic cohort.
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Sleep quality and mood changes were detected in 
probiotics treated individuals of Cluster 1
As shown in Figure 5A, a significant reduction (P=0.03) 
was detected between time points T0-T1 and confirmed 
for T0-T2 and T0-T3 for the Pittsburgh Sleep Quality Index 
(PSQI). The PSQI global score is inversely correlated to 
the sleep quality (the lower the score, the better the sleep 
quality). The identified reduction indicates a sleep quality 
improvement for the probiotics treated individuals of 
Cluster 1.
Other significant changes were detected for the depression, 
anger, and fatigue subscales of the Profile and Mood State 
(POMS) psychological variables. Specifically, between 
T0-T1 and T0-T3 for anger (P=0.08, 0.02; Figure 5B) and 
depression (P=0.08, 0.06; Figure 5C) indexes, and between 
T0-T1 (P=0.04), T0-T2 (P=0.02), and T0-T3 (P=0.03) for 
the fatigue subscale (Figure 5D). It is noteworthy a clear 
descending trend for all mentioned psychological variables 
also in Cluster 3, even though these differences were not 
significant, probably due to the low sample size of the 




Cluster: 1 Cluster: 2 Cluster: 3
Placebo
Probiotic












Wilcox test − by TimePoint, treatment, and cluster
Pittsburg Sleep Quality Index (PSQI)A
0.077
0.018
Cluster: 1 Cluster: 2 Cluster: 3
Placebo
Probiotic















Wilcox test − by TimePoint, treatment, and cluster
Anger subscale of the Profile of Mood State (POMS)B
0.079
0.062
Cluster: 1 Cluster: 2 Cluster: 3
Placebo
Probiotic
















Wilcox test − by TimePoint, treatment, and cluster




Cluster: 1 Cluster: 2 Cluster: 3
Placebo
Probiotic



















Wilcox test − by TimePoint, treatment, and cluster
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Figure 5. Wilcoxon Rank Sum tests between time points T0-T1, T0-T2, T0-T3. P-values are corrected for multiple testing using 
the Benjamini-Hochberg correction method and only adjusted P-values lower than 0.1 are reported. (A) Pittsburgh Sleep Quality 
Index (PSQI), stratified by cluster and treatment. (B) Anger subscale for the Profile of Mood State (POMS) psychological variable, 
stratified by cluster and treatment. (C) Depression subscale for the Profile of Mood State (POMS) psychological variable, stratified 
by cluster and treatment. (D) Fatigue subscale for the Profile of Mood State (POMS) psychological variable, stratified by cluster 
and treatment.
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4. Discussion
Biodiversity measures stratified individuals in three 
clusters related to their microbiota
In the present work the possible effect caused by the intake 
of B. longum, L. fermentum, L. rhamnosus and L. plantarum 
strains for 6 weeks (followed by a 3 week-washout) on 
the gut microbiota composition of a cohort of 33 healthy 
subjects was investigated.
A robust bioinformatic pipeline was implemented to 
analyse and characterise the metabarcoding data; a 
series of exploratory analyses were performed targeting 
particular effects with a possible biological correspondence, 
which could be related to the cognitive and emotional 
improvements we assessed in our previous study (Marotta et 
al., 2019). Biodiversity measures did not detect a significant 
diversity within the samples (α-diversity) but a sample-
specific effect was found between samples (β-diversity). This 
finding led to perform a statistical analysis using a mixed-
effects model, through which several minor significant 
effects were found. The 33 individuals were clustered into 
three groups/bacteriotypes at the baseline; each one of them 
responded distinctly to the treatments. Cluster 1 and 2 were 
most impacted by the probiotic treatment, while Cluster 3 
responded more to the placebo treatment. Furthermore, 
Cluster 1 responded throughout the whole treatment, while 
Cluster 2 and Cluster 3 had, respectively, a late and an 
early response. Those behaviours reinforce the concept 
that individuals with diverse bacteriotypes might respond 
differently to the same treatment. In addition, stratification 
of individuals according to their bacterial composition may 
be useful to better understand and predict the responses to 
specific treatments, such as probiotic interventions (Cheng 
and Ning, 2019; Christensen et al., 2018).
Maltodextrin has a bifidogenic effect
Focusing on SVs related to the probiotic species, it was 
observed that some Bifidobacterium-related SVs (SV15 
and SV121) decreased both in the placebo and probiotic 
groups, but others, such as SV34-B. longum and SV228-
Bifidobacterium significantly increased in the placebo 
cohort both in Cluster 1 and Cluster 2. Their presence in 
the control subjects, who were administered maltodextrin, 
is also in line with data reported in a previous work (Watson 
et al., 2013) where authors observed that the majority of 
the culturable bifidobacterial strains (including 10 strains 
of B. longum) were capable of growing in maltodextrin 
rich media. Tandon and colleagues (2019) observed 
the same behaviour of the bifidobacterial population in 
a randomized, double-blind, placebo-controlled, dose-
response relationship study led to investigate the efficacy 
of fructo-oligosaccharides on human gut microbiota, where 
maltodextrin was used as control.
From this perspective, this study does not include a true 
placebo cohort which may have prevented to capture time 
dependent oscillations in abundances of relevant taxa; 
further, since maltodextrins are broadly used as placebo 
treatment, their bifidogenic effect needs to be deeply 
evaluated in future clinical trials involving bifidobacteria. 
Considering our data, we suggest that participants of this 
study were subjected to two different treatments rather 
than one: a ‘synbiotic’ administration (probiotics and 
maltodextrin) and a ‘prebiotic’ assumption (maltodextrin).
Cluster 1 individuals displayed different gut composition 
following the prebiotic and synbiotic treatments
The gut composition of individuals who received the 
synbiotics in Cluster 1 are selectively characterised by the 
presence of L. rhamnosus and C. leptum at the beginning 
of the treatments and then of Mogibacterium (described 
in 2000 to include strains isolated from the human 
periodontal environment; Nakazawa et al., 2000) at the 
end. C. leptum belongs to Clostridium Cluster IV which 
was reduced in patients with depression and anhedonia and 
it was negatively associated with scores in Quick Inventory 
of Depressive Symptoms-Self-Rated (QIDS-SR) and the 
Generalized Anxiety Disorder (GAD)-7 (Mason et al., 2020). 
The effect of probiotics administration on the abundance 
of C. leptum was also observed by Sato and colleagues 
(2017) where patients with type-2 diabetes had higher 
counts of C. leptum after 16 weeks of probiotics (L. casei 
Shirota) assumption. The synbiotic treatment specifically 
reduced the levels of Faecalibacterium, which was among 
the signature taxa of this cluster. This taxon is usually lower 
in MDD patients but there is still a lack of congruence 
across investigations (Barandouzi et al., 2020; Cheung et 
al., 2019).
The prebiotic treatment is associated with higher levels of 
Anaerotignum (described in 2017 following the isolation 
of strains from a methanogenic reactor; Ueki et al., 2017), 
S. thermophilus, Turicibacter and D. invisus. Among these 
species, it is interesting to report a reduced abundance of 
Turicibacter spp. was observed in socially defeated mice 
and was strongly correlated to pro-inflammatory cytokine 
changes within the prefrontal cortex (Szyszkowicz et al., 
2017). However, this has to be further investigated, as 
Turicibacter levels were also found to be higher in depressed 
subjects (Kelly et al., 2016). As for D. invisus, it is usually 
lower in MDD patients and in other autoimmune diseases, 
including Crohn’s disease, ulcerative colitis and rheumatoid 
arthritis (Lee et al., 2019).
Prebiotic administration was also related to reduced levels of 
Butyricimonas, Lachnospira, Alistipes and R. lactatiformans 
(isolated in 2016 from human faeces; Shkoporov et al., 
2016). The decrease of Butyricimonas spp. may have a 
positive effect on the individuals: Butyricimonas members 
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were found to be at higher levels in the gut microbiota of 
patients with clinically significant depression compared 
to control patients (Jiang et al., 2015). As for Lachnospira, 
no consensus data have been obtained so far, as Cheung 
and colleagues reported that this taxon could be related 
to MDD as well as to healthy subjects (Barandouzi et al., 
2020; Cheung et al., 2019).
A significant association with depression was shown for 
Alistipes both in human cases as well as in mice subjected 
to stress over an extended time period. Since high levels 
of this taxon in the gut microbiota were also linked to 
chronic fatigue syndrome and irritable bowel syndrome 
(IBS), it has been suggested that Alistipes may promote 
depression through inflammatory pathways. In addition, 
Alistipes species are indole-positive and may thus influence 
tryptophan availability (the precursor of serotonin), 
disrupting the balance in the intestinal serotonergic 
system (Naseribafrouei et al., 2014). They are also high 
metabolisers of proteins and amino acids and, as such, they 
could trigger the production of toxic compounds such as 
ammonia, putrescine, and phenol (Cheung et al., 2019). 
However, these data are not concordant with what observed 
from Zheng and colleagues who reported that Alistipes were 
overrepresented in healthy control subjects compared to 
patients diagnosed with MDD (Zheng et al., 2016).
Prebiotic treatment in Cluster 2 has an opposite effect of 
the synbiotic in Cluster 1
In Cluster 2, the prebiotic supplementation induced a 
general oscillation of the abundance levels of Eubacterium, 
Blautia and Lachnospiraceae spp., which characterized 
the bacteriotype of this group. Kim and colleagues (2020) 
suggested that the reduction in the relative abundances 
of Eubacterium is related to the increase of the brain-
derived neurotrophic factor in the serum, improving 
brain functions. On the contrary respect to Cluster 1, the 
comparison between the prebiotic and synbiotic treatments 
showed that Alistipes spp. and Lachnospira spp. increased 
in Cluster 2 individuals.
The synbiotic intervention specifically led to a lower 
abundance of Ruminococcaceae (heterotypic synonym of 
family Oscillispiraceae): at family level, it was observed that 
these taxa were lower in depressed subjects compared to 
the control group (Jiang et al., 2015) and were correlated 
with behavioural changes induced by stress in mice 
(Bangsgaard Bendtsen et al., 2012). Conversely, prebiotics 
reduced the levels of Blautia, Clostridium, Escherichia 
and Agathobaculum spp.: although no data have been 
reported yet on the association of Agathobaculum (a strictly 
anaerobic and butyrate-producing strain isolated from the 
faeces of a healthy 23-year-old Korean female, Ahn et al., 
2016), with stress-related disorders and there is a lack of 
consensus related to the presence of Escherichia in MDD 
patients, this effect could be considered beneficial for this 
cluster, as both Blautia spp. and Clostridium are usually 
found at higher levels in patients with MDD (Cheung et al., 
2019; Jiang et al., 2015). Conversely, Faecalibacterium and 
R. inulinivorans increased at the end of prebiotic treatment: 
this species has been shown to have beneficial effects in 
specific conditions (i.e. atherosclerosis, Liu et al., 2020a) 
but no particular correlation has been found with mental 
or stress-related disorders (Cheung et al., 2019).
Treatments in Cluster 3 changed the relative abundance 
of Phascholarctobacterium faecium, Subdoligranulum 
and Eubacterium spp.
The assumption of the synbiotic in Cluster 3 individuals 
increased the relative abundance of Subdoligranulum and 
P. faecium and Eubacterium spp. (which characterised the 
bacteriotype at the baseline). It is interesting to note that 
P. faecium and, in general, family Acidaminococcaceae are 
more correlated to patients with active MDD (Jiang et al., 
2015) and with both IBS and depression (Jeffery et al., 
2012) rather that with healthy subjects. On the contrary, 
Subdoligranulum are depleted in subjects with IBS and 
depression, so its presence in the synbiotic cohort can be 
interpreted as a positive effect of this treatment (Liu et al., 
2020b). This taxon is capable of producing short chain fatty 
acids (in particular butyrate) that protect the intestinal 
mucosa and regulate the immune system. More specifically, 
short-chain fatty acids (SCFA) play an important role in 
the differentiation of T cells and as histone deacetylase 
inhibitors, which were found to have immunosuppressive 
and anti-inflammatory functions and have been explored 
as potential novel antidepressants (Cheung et al., 2019). 
R. hominis, Anaerotignum spp. (similarly to Cluster 1), 
Pseudoflavonifractor, Eubacterium (conversely to the 
synbiotic treatment) and Sporobacter (among the signature 
taxa of this Cluster) were significantly abundant following 
the prebiotic treatment while I. bartletti, Bacteroides and 
B. obeum decreased. Sporobacter and Pseudoflavonifractor 
are among the common taxa found in the human gut 
microbiota; as for R. hominis, although no data are available 
regarding the direct positive or negative connection of 
this species and stress-related disorders, the reduction in 
the abundance of butyrate-producing Lachnospiraceae 
members, (including R. hominis) which are beneficial for 
the integrity and function of intestinal barrier, was involved 
in the formation of stress-induced visceral hypersensitivity 
for which R. hominis was proposed as a candidate potential 
probiotic (Zhang et al., 2019). As for I. bartlettii, it is 
interesting to report that it was found more frequently in 
the faecal samples of children with neurodevelopmental 
disorders compared to the control subjects (Bojovic et 
al., 2020). Finally, Bacteroides spp. exhibited divergent 
directionality and were found to be associated both with 
MDD as well as with healthy status, so no conclusions 
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can be made on the effect of their reduction in this cohort 
(Barandouzi et al., 2020).
5. Conclusions
Although no consensus observations on the biological 
significance of particular components of the gut microbiota 
on mood disorders have been obtained yet, the present 
study shows that both the ‘synbiotic’ and the ‘prebiotic’ 
intake over a period of 6 weeks significantly changed the 
composition of the gut microbiota.
A debate is still ongoing whether the probiotic 
supplementation alters successfully the microbiota 
composition (Kristensen et al., 2016); in this perspective, 
Pinto-Sanchez and colleagues (2017) observed that probiotic 
administration in patients with IBS led to changes in urine 
metabolic profiles, brain activity and to antidepressant 
effects, but no detectable effects on the gut microbiota 
composition were noticed. Nevertheless, it has been 
demonstrated that probiotic treatments impact on both 
the gut microbiota gene expression (with potential anti-
inflammatory effects) and the gut barrier function (as also 
shown by the probiotic strains used in the present study 
– Pane M, personal communication); which can lead to 
an effect on the cognitive function (Chahwan et al., 2019).
Overall, this study offers evidence that probiotics 
supplementation has variable impacts depending on the 
gut microbiota bacteriotypes (i.e. Cluster 1, 2 and 3). In 
some cases, the shifts were towards microbial populations 
generally related to a healthy mood status (i.e. higher 
abundance of C. leptum and Subdoligranulum in Cluster 
1 and 3, respectively) and suggests some mechanisms (i.e. 
SCFA production related to Subdoligranulum) which might 
rationalise the positive effects of the supplementation on the 
depressive mood state and sleep quality we observed in our 
previous work (Marotta et al., 2019). Particularly, variations 
of microbiota compositions were found to be statistically 
related to sleep quality improvement and to a descending 
rate of depression, anger and fatigue in probiotic-treated 
individuals of Cluster 1.
Overall, these findings should be interpreted with caution: 
first of all, further studies are necessary on a larger and 
more homogeneous cohort of individuals, taking fully 
into account the effects of gender, diet, body mass index, 
presence of inflammation, bacteriotypes, and other factors 
that may be important covariates affecting the faecal 
microbiota.
As for diet, it is well established that it is one of the major 
modulators of the microbiota, therefore its monitoring is 
of utmost interest to better understand microbial dynamics 
and link them to other metabolic and physiological 
parameters (Bowyer et al., 2018). However, the monitoring 
of young healthy individuals for 6 weeks (9 including 
washout) proved to be a very challenging task, with too 
partial data that could not be used for associations.
Indeed, in this study, we tried to move from an effectiveness 
perspective (the whole cohort) to an efficacy-focused one 
(the clusters/bacteriotypes), revealing some complexities on 
the microbial background related to the effects described by 
Marotta et al. (2019) on almost the same cohort. Shedding 
light on these variables, especially on a healthy individual’s 
cohort, is expected to allow a better development of 
psychobiotic treatment strategies. This will contribute to 
the definition of probiotics as an adjunct therapy or for the 
prevention of mood-related disorders.
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